HIV protease inhibitors are peptide-like chemicals that competitively inhibit the action of the virus aspartyl protease. A peptide linkage consisting of –NH-CO- is replaced by an hydroxyethylen group (-CH2-CH(OH)-) which the protease is unable to cleave. HIV-1 protease cleaves the sequences containing the dipeptides Tyr-Pro or Phe-Pro was the basic design criterion. Indinavir is Phe-Gly. The terminal phenyl constituents contribute hydrophobic binding to increase potency. HIV inhibitors change Vo but not Vmax.
Thank You So Much! Please Rate this answer as you wish.
sdent ork 10/27/17 50% 1st attempt Structure-based drug design strategies often devise competitive Inhibitors that bind...